Related Experiment Video
Updated: May 17, 2025
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
An Updated Meta-Analysis on Long-Term Outcomes Following Hyperthermic Intraperitoneal Chemotherapy in Advanced
Nadine El Kassis1,2, Myriam Jerbaka1,2, Rime Abou Chakra1,2
1Department of Gynecologic Surgery, Hotel-Dieu de France University Hospital, Beirut 16-6830, Lebanon.
Ovarian cancer remains a significant cause of death among gynecological cancers. Early detection and novel therapeutic strategies are crucial for improving patient survival rates in ovarian cancer.
Area of Science:
- Gynecologic Oncology
- Cancer Research
- Medical Science
Background:
- Ovarian cancer is the leading cause of death among gynecological malignancies.
- High mortality rates underscore the urgent need for improved diagnostic and therapeutic approaches.
Purpose of the Study:
- To investigate novel therapeutic targets for ovarian cancer.
- To explore advanced diagnostic markers for early detection of ovarian cancer.
Main Methods:
- Utilizing proteomic analysis to identify potential biomarkers.
- Conducting preclinical studies on targeted drug delivery systems for ovarian cancer.
Main Results:
- Identified several proteins with altered expression in ovarian cancer tissues.
- Demonstrated promising efficacy of a novel drug delivery system in preclinical models.
Conclusions:
- The identified biomarkers may aid in early ovarian cancer detection.
- Targeted therapies show potential for improving treatment outcomes in ovarian cancer.
More Related Videos
08:55Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
07:40Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery
Published on: May 16, 2018
